David Ashby is bloodstock underwriter for Amlin Plus, the specialist bloodstock arm of Amlin plc, one of the leading independent Lloyd’s insurance groups. "I can see significant benefits to both the insured and the insurer from an annual Equinalysis review, and Amlin Plus would certainly reflect this by a reduction in premium," he says. "Some of the major issues with loss of use and veterinary fee insurance, and hence the reason for higher premiums, are the very high costs involved in diagnostic work for subtle or hard-to-find lameness. I am hopeful that Equinalysis could help to significantly reduce these costs and thus horse owners’ insurance premiums as well. Amlin Plus is committed to supporting ideas that reduce costs and give its clients a fuller and better understanding of their horses’ capabilities and potential, given that the examination costs are reasonable. Amlin Plus is positioned at the high-value end of the market, and it is likely that we will make an annual Equinalysis review a no-cost benefit of our policy. That said, I believe the work of Equinalysis should see a reduction of premiums to all horse owners who use the system, as a credit for their good husbandry and horsemanship."

Amlin Plus website: www.amlinplus.co.uk/

Contact David via email on: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it